Annual Accounts Payable
$239.30 M
-$3.10 M-1.28%
December 31, 2024
Summary
- As of February 26, 2025, WST annual accounts payable is $239.30 million, with the most recent change of -$3.10 million (-1.28%) on December 31, 2024.
- During the last 3 years, WST annual accounts payable has risen by +$7.10 million (+3.06%).
- WST annual accounts payable is now -1.28% below its all-time high of $242.40 million, reached on December 31, 2023.
Performance
WST Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$239.30 M
+$15.00 M+6.69%
December 1, 2024
Summary
- As of February 26, 2025, WST quarterly accounts payable is $239.30 million, with the most recent change of +$15.00 million (+6.69%) on December 1, 2024.
- Over the past year, WST quarterly accounts payable has dropped by -$3.10 million (-1.28%).
- WST quarterly accounts payable is now -3.59% below its all-time high of $248.20 million, reached on March 31, 2022.
Performance
WST Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
WST Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.3% | -1.3% |
| 3 y3 years | +3.1% | -1.3% |
| 5 y5 years | +52.6% | -1.3% |
WST Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.3% | +11.1% | -3.6% | +26.7% |
| 5 y | 5-year | -1.3% | +52.6% | -3.6% | +52.6% |
| alltime | all time | -1.3% | +1597.2% | -3.6% | +1672.6% |
West Pharmaceutical Services Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $239.30 M(-1.3%) | - |
| Dec 2024 | - | $239.30 M(+6.7%) |
| Sep 2024 | - | $224.30 M(+6.0%) |
| Jun 2024 | - | $211.70 M(-11.8%) |
| Mar 2024 | - | $240.10 M(-0.9%) |
| Dec 2023 | $242.40 M(+12.5%) | $242.40 M(+10.3%) |
| Sep 2023 | - | $219.80 M(+0.8%) |
| Jun 2023 | - | $218.00 M(-6.8%) |
| Mar 2023 | - | $233.80 M(+8.5%) |
| Dec 2022 | $215.40 M(-7.2%) | $215.40 M(+14.0%) |
| Sep 2022 | - | $188.90 M(-14.1%) |
| Jun 2022 | - | $220.00 M(-11.4%) |
| Mar 2022 | - | $248.20 M(+6.9%) |
| Dec 2021 | $232.20 M(+9.0%) | $232.20 M(+11.8%) |
| Sep 2021 | - | $207.70 M(+1.3%) |
| Jun 2021 | - | $205.10 M(+0.4%) |
| Mar 2021 | - | $204.30 M(-4.1%) |
| Dec 2020 | $213.10 M(+35.9%) | $213.10 M(+18.2%) |
| Sep 2020 | - | $180.30 M(+11.1%) |
| Jun 2020 | - | $162.30 M(+2.8%) |
| Mar 2020 | - | $157.90 M(+0.7%) |
| Dec 2019 | $156.80 M(+20.2%) | $156.80 M(+7.9%) |
| Sep 2019 | - | $145.30 M(-4.5%) |
| Jun 2019 | - | $152.10 M(+10.5%) |
| Mar 2019 | - | $137.70 M(+5.6%) |
| Dec 2018 | $130.40 M(-5.6%) | $130.40 M(+4.2%) |
| Sep 2018 | - | $125.20 M(-0.8%) |
| Jun 2018 | - | $126.20 M(-1.1%) |
| Mar 2018 | - | $127.60 M(-7.6%) |
| Dec 2017 | $138.10 M(+13.2%) | $138.10 M(+13.3%) |
| Sep 2017 | - | $121.90 M(-6.9%) |
| Jun 2017 | - | $130.90 M(+23.4%) |
| Mar 2017 | - | $106.10 M(-13.0%) |
| Dec 2016 | $122.00 M(+1.8%) | $122.00 M(+23.2%) |
| Sep 2016 | - | $99.00 M(-7.7%) |
| Jun 2016 | - | $107.30 M(+10.1%) |
| Mar 2016 | - | $97.50 M(-18.6%) |
| Dec 2015 | $119.80 M(+16.2%) | $119.80 M(+28.0%) |
| Sep 2015 | - | $93.60 M(+2.4%) |
| Jun 2015 | - | $91.40 M(+3.3%) |
| Mar 2015 | - | $88.50 M(-14.2%) |
| Dec 2014 | $103.10 M(-4.5%) | $103.10 M(+12.8%) |
| Sep 2014 | - | $91.40 M(-3.3%) |
| Jun 2014 | - | $94.50 M(-4.0%) |
| Mar 2014 | - | $98.40 M(-8.9%) |
| Dec 2013 | $108.00 M(+5.0%) | $108.00 M(+25.1%) |
| Sep 2013 | - | $86.30 M(-2.4%) |
| Jun 2013 | - | $88.40 M(-3.5%) |
| Mar 2013 | - | $91.60 M(-11.0%) |
| Dec 2012 | $102.90 M(+14.6%) | $102.90 M(+26.6%) |
| Sep 2012 | - | $81.30 M(-5.0%) |
| Jun 2012 | - | $85.60 M(+3.5%) |
| Mar 2012 | - | $82.70 M(-7.9%) |
| Dec 2011 | $89.80 M(+42.1%) | $89.80 M(+25.2%) |
| Sep 2011 | - | $71.70 M(-2.3%) |
| Jun 2011 | - | $73.40 M(+10.9%) |
| Mar 2011 | - | $66.20 M(+4.7%) |
| Dec 2010 | $63.20 M(-7.6%) | $63.20 M(+12.3%) |
| Sep 2010 | - | $56.30 M(-8.3%) |
| Jun 2010 | - | $61.40 M(-7.5%) |
| Mar 2010 | - | $66.40 M(-2.9%) |
| Dec 2009 | $68.40 M(+1.2%) | $68.40 M(+23.7%) |
| Sep 2009 | - | $55.30 M(-8.9%) |
| Jun 2009 | - | $60.70 M(+16.7%) |
| Mar 2009 | - | $52.00 M(-23.1%) |
| Dec 2008 | $67.60 M(-15.9%) | $67.60 M(+9.6%) |
| Sep 2008 | - | $61.70 M(-11.6%) |
| Jun 2008 | - | $69.80 M(+20.6%) |
| Mar 2008 | - | $57.90 M(-28.0%) |
| Dec 2007 | $80.40 M | $80.40 M(+55.2%) |
| Sep 2007 | - | $51.80 M(-3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2007 | - | $53.50 M(-10.1%) |
| Mar 2007 | - | $59.50 M(-2.8%) |
| Dec 2006 | $61.20 M(+33.6%) | $61.20 M(+28.8%) |
| Sep 2006 | - | $47.50 M(-7.8%) |
| Jun 2006 | - | $51.50 M(+8.6%) |
| Mar 2006 | - | $47.40 M(+3.5%) |
| Dec 2005 | $45.80 M(+56.3%) | $45.80 M(+29.4%) |
| Sep 2005 | - | $35.40 M(+2.9%) |
| Jun 2005 | - | $34.40 M(+47.0%) |
| Mar 2005 | - | $23.40 M(-20.1%) |
| Dec 2004 | $29.30 M(+2.4%) | $29.30 M(+11.8%) |
| Sep 2004 | - | $26.20 M(+6.9%) |
| Jun 2004 | - | $24.50 M(-7.9%) |
| Mar 2004 | - | $26.60 M(-7.0%) |
| Dec 2003 | $28.60 M(+49.0%) | $28.60 M(+13.9%) |
| Sep 2003 | - | $25.10 M(+14.6%) |
| Jun 2003 | - | $21.90 M(+1.4%) |
| Mar 2003 | - | $21.60 M(+12.5%) |
| Dec 2002 | $19.20 M(-15.0%) | $19.20 M(-2.5%) |
| Sep 2002 | - | $19.70 M(-3.4%) |
| Jun 2002 | - | $20.40 M(-7.3%) |
| Mar 2002 | - | $22.00 M(-2.7%) |
| Dec 2001 | $22.60 M(-3.8%) | $22.60 M(-5.8%) |
| Sep 2001 | - | $24.00 M(-8.4%) |
| Jun 2001 | - | $26.20 M(+3.1%) |
| Mar 2001 | - | $25.40 M(+8.1%) |
| Dec 2000 | $23.50 M(-7.8%) | $23.50 M(-8.6%) |
| Sep 2000 | - | $25.70 M(+13.7%) |
| Jun 2000 | - | $22.60 M(+0.9%) |
| Mar 2000 | - | $22.40 M(-12.2%) |
| Dec 1999 | $25.50 M(+22.6%) | $25.50 M(+39.3%) |
| Sep 1999 | - | $18.30 M(-8.0%) |
| Jun 1999 | - | $19.90 M(+8.2%) |
| Mar 1999 | - | $18.40 M(-11.5%) |
| Dec 1998 | $20.80 M(+11.8%) | $20.80 M(+28.4%) |
| Sep 1998 | - | $16.20 M(+3.2%) |
| Jun 1998 | - | $15.70 M(-15.6%) |
| Mar 1998 | - | $18.60 M(0.0%) |
| Dec 1997 | $18.60 M(-22.2%) | $18.60 M(+11.4%) |
| Sep 1997 | - | $16.70 M(-22.7%) |
| Jun 1997 | - | $21.60 M(0.0%) |
| Mar 1997 | - | $21.60 M(-9.6%) |
| Dec 1996 | $23.90 M(+6.2%) | $23.90 M(+2.6%) |
| Sep 1996 | - | $23.30 M(-0.9%) |
| Jun 1996 | - | $23.50 M(+4.0%) |
| Mar 1996 | - | $22.60 M(+0.4%) |
| Dec 1995 | $22.50 M(+16.6%) | $22.50 M(+13.6%) |
| Sep 1995 | - | $19.80 M(+3.1%) |
| Jun 1995 | - | $19.20 M(+12.9%) |
| Mar 1995 | - | $17.00 M(-11.9%) |
| Dec 1994 | $19.30 M(+36.9%) | $19.30 M(+36.9%) |
| Sep 1994 | - | $14.10 M(-7.2%) |
| Jun 1994 | - | $15.20 M(+6.3%) |
| Mar 1994 | - | $14.30 M(+1.4%) |
| Dec 1993 | $14.10 M(-30.9%) | $14.10 M(-13.0%) |
| Sep 1993 | - | $16.20 M(-12.0%) |
| Jun 1993 | - | $18.40 M(+14.3%) |
| Mar 1993 | - | $16.10 M(-21.1%) |
| Dec 1992 | $20.40 M(+24.4%) | $20.40 M(+10.3%) |
| Sep 1992 | - | $18.50 M(-1.1%) |
| Jun 1992 | - | $18.70 M(-3.6%) |
| Mar 1992 | - | $19.40 M(+18.3%) |
| Dec 1991 | $16.40 M(-8.9%) | $16.40 M(+16.3%) |
| Sep 1991 | - | $14.10 M(-7.2%) |
| Jun 1991 | - | $15.20 M(-20.4%) |
| Mar 1991 | - | $19.10 M(+6.1%) |
| Dec 1990 | $18.00 M(+10.4%) | $18.00 M(+20.8%) |
| Sep 1990 | - | $14.90 M(-13.4%) |
| Jun 1990 | - | $17.20 M(+27.4%) |
| Mar 1990 | - | $13.50 M(-17.2%) |
| Dec 1989 | $16.30 M | $16.30 M |
FAQ
- What is West Pharmaceutical Services annual accounts payable?
- What is the all time high annual accounts payable for West Pharmaceutical Services?
- What is West Pharmaceutical Services annual accounts payable year-on-year change?
- What is West Pharmaceutical Services quarterly accounts payable?
- What is the all time high quarterly accounts payable for West Pharmaceutical Services?
- What is West Pharmaceutical Services quarterly accounts payable year-on-year change?
What is West Pharmaceutical Services annual accounts payable?
The current annual accounts payable of WST is $239.30 M
What is the all time high annual accounts payable for West Pharmaceutical Services?
West Pharmaceutical Services all-time high annual accounts payable is $242.40 M
What is West Pharmaceutical Services annual accounts payable year-on-year change?
Over the past year, WST annual accounts payable has changed by -$3.10 M (-1.28%)
What is West Pharmaceutical Services quarterly accounts payable?
The current quarterly accounts payable of WST is $239.30 M
What is the all time high quarterly accounts payable for West Pharmaceutical Services?
West Pharmaceutical Services all-time high quarterly accounts payable is $248.20 M
What is West Pharmaceutical Services quarterly accounts payable year-on-year change?
Over the past year, WST quarterly accounts payable has changed by -$3.10 M (-1.28%)